Widespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides.
Vanesa LafargaOleksandra SirozhIrene Díaz-LópezAntonio GalarretaMisaru HisaokaEduardo ZarzuelaJasminka BoskovicBogdan JovanovicRafael Fernandez-LeiroJaime MuñozGeorg StoecklinIván VentosoOscar Fernandez-CapetilloPublished in: The EMBO journal (2021)
Due to their capability to transport chemicals or proteins into target cells, cell-penetrating peptides (CPPs) are being developed as therapy delivery tools. However, and despite their interesting properties, arginine-rich CPPs often show toxicity for reasons that remain poorly understood. Using a (PR)n dipeptide repeat that has been linked to amyotrophic lateral sclerosis (ALS) as a model of an arginine-rich CPP, we here show that the presence of (PR)n leads to a generalized displacement of RNA- and DNA-binding proteins from chromatin and mRNA. Accordingly, any reaction involving nucleic acids, such as RNA transcription, translation, splicing and degradation, or DNA replication and repair, is impaired by the presence of the CPPs. Interestingly, the effects of (PR)n are fully mimicked by protamine, a small arginine-rich protein that displaces histones from chromatin during spermatogenesis. We propose that widespread coating of nucleic acids and consequent displacement of RNA- and DNA-binding factors from chromatin and mRNA accounts for the toxicity of arginine-rich CPPs, including those that have been recently associated with the onset of ALS.
Keyphrases
- amyotrophic lateral sclerosis
- nitric oxide
- transcription factor
- dna binding
- amino acid
- nucleic acid
- dna damage
- gene expression
- oxidative stress
- single cell
- binding protein
- circulating tumor
- cell therapy
- genome wide
- induced apoptosis
- stem cells
- cell free
- protein protein
- small molecule
- dna methylation
- cell cycle arrest
- signaling pathway
- replacement therapy